These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 8383518
1. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W. Chirality; 1993; 5(1):15-9. PubMed ID: 8383518 [Abstract] [Full Text] [Related]
2. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise. Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W. Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077 [Abstract] [Full Text] [Related]
3. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin). Clementi WA, Garvey TQ, Clifton GD, McCoy RA, Brandt S, Schwartz S. Chirality; 1994 May; 6(3):169-74. PubMed ID: 8024947 [Abstract] [Full Text] [Related]
4. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study. Egginger G, Lindner W, Kahr S, Stoschitzky K. Chirality; 1993 May; 5(7):505-12. PubMed ID: 8240927 [Abstract] [Full Text] [Related]
5. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies. Stoschitzky K, Klein W, Stark G, Stark U, Zernig G, Graziadei I, Lindner W. Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749 [Abstract] [Full Text] [Related]
6. Hemodynamic effects of reboxetine in healthy male volunteers. Denolle T, Pellizzoni C, Jannuzzo MG, Poggesi I. Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064 [Abstract] [Full Text] [Related]
7. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers. Paradiso-Hardy FL, Walker SE, Bowles SK. Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351 [Abstract] [Full Text] [Related]
8. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration. Martins ML, Pierossi MA, Moraes LA, Ribeiro W, Abbib Júnior E, Mendes GB, Poli A, De Nucci G, Muscará MN. Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287 [Abstract] [Full Text] [Related]
9. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Fornasini G, Monti N, Brogin G, Gallina M, Eandi M, Persiani S, Bani M, Della Pepa C, Zara G, Strolin Benedetti M. Chirality; 1997 Aug; 9(3):297-302. PubMed ID: 9176996 [Abstract] [Full Text] [Related]
10. Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man. Stoschitzky K, Lindner W, Rath M, Leitner C, Uray G, Zernig G, Moshammer T, Klein W. Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):474-8. PubMed ID: 2739756 [Abstract] [Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers. Gumbhir-Shah K, Kellerman DJ, DeGraw S, Koch P, Jusko WJ. J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561 [Abstract] [Full Text] [Related]
12. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ. Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615 [Abstract] [Full Text] [Related]
13. A stereoselective central hypotensive action of atenolol. Pearson AA, Gaffney TE, Walle T, Privitera PJ. J Pharmacol Exp Ther; 1989 Sep; 250(3):759-63. PubMed ID: 2778713 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris. van der Vijgh WJ, Majid PA, de Feyter PJ, Wardeh R, van der Wall EE. Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122 [Abstract] [Full Text] [Related]
15. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol]. Stoschitzky K, Lindner W. Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978 [Abstract] [Full Text] [Related]
16. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project. Am J Hypertens; 2004 Mar 15; 17(3):245-51. PubMed ID: 15001199 [Abstract] [Full Text] [Related]
17. Effect of rifampicin on the pharmacokinetics of atenolol. Lilja JJ, Juntti-Patinen L, Neuvonen PJ. Basic Clin Pharmacol Toxicol; 2006 Jun 15; 98(6):555-8. PubMed ID: 16700816 [Abstract] [Full Text] [Related]
18. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen. Główka FK, Caldwell J. Chirality; 2002 Oct 15; 14(9):736-41. PubMed ID: 12237835 [Abstract] [Full Text] [Related]
19. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat. Bode W, Toet AE, Stolker AA, van Ginkel LA, Groen K, Wemer J, de Wildt DJ. Chirality; 1995 Oct 15; 7(8):626-31. PubMed ID: 8593256 [Abstract] [Full Text] [Related]
20. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. Rousseau MF, Pouleur H, Cocco G, Wolff AA. Am J Cardiol; 2005 Feb 01; 95(3):311-6. PubMed ID: 15670536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]